KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Microvision (MVIS) Operating Expenses: 2010-2025

Historic Operating Expenses for Microvision (MVIS) over the last 8 years, with Sep 2025 value amounting to $12.0 million.

  • Microvision's Operating Expenses fell 21.60% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.2 million, marking a year-over-year decrease of 38.10%. This contributed to the annual value of $82.7 million for FY2024, which is 11.44% down from last year.
  • As of Q3 2025, Microvision's Operating Expenses stood at $12.0 million, which was down 14.83% from $14.1 million recorded in Q2 2025.
  • In the past 5 years, Microvision's Operating Expenses registered a high of $26.4 million during Q1 2024, and its lowest value of $6.7 million during Q2 2021.
  • In the last 3 years, Microvision's Operating Expenses had a median value of $21.4 million in 2023 and averaged $19.7 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 108.15% in 2022, then crashed by 46.65% in 2025.
  • Quarterly analysis of 5 years shows Microvision's Operating Expenses stood at $13.1 million in 2021, then grew by 6.34% to $14.0 million in 2022, then surged by 72.53% to $24.1 million in 2023, then tumbled by 33.55% to $16.0 million in 2024, then decreased by 21.60% to $12.0 million in 2025.
  • Its last three reported values are $12.0 million in Q3 2025, $14.1 million for Q2 2025, and $14.1 million during Q1 2025.